Mieke A. Van Der Mescht
Pretoria, GT, South Africa
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Humoral and cellular immunogenicity of COVID-19 vaccine boosters in participants with advanced HIV disease.
Journal: The Journal of infection
Published: October 28, 2025
Sodium, Potassium-Adenosine Triphosphatase as a Potential Target of the Anti-Tuberculosis Agents, Clofazimine and Bedaquiline.
Journal: International journal of molecular sciences
Published: September 16, 2024
Vascular endothelial growth factor A: friend or foe in the pathogenesis of HIV and SARS-CoV-2 infections?
Journal: Frontiers in cellular and infection microbiology
Published: July 02, 2024
SARS-CoV-2 BA.4/5 infection triggers more cross-reactive FcγRIIIa signaling and neutralization than BA.1, in the context of hybrid immunity.
Journal: Journal of virology
Published: July 02, 2024
SARS-CoV-2 seropositivity amongst healthcare workers in South Africa during the Omicron wave: natural infection versus vaccination.
Journal: Journal of clinical pathology
Published: June 21, 2024
Aberrant innate immune profile associated with COVID-19 mortality in Pretoria, South Africa.
Journal: Clinical immunology (Orlando, Fla.)
Published: May 21, 2024
Comparison of platelet-and endothelial-associated biomarkers of disease activity in people hospitalized with Covid-19 with and without HIV co-infection.
Journal: Frontiers in immunology
Published: June 06, 2023
Despite delayed kinetics, people living with HIV achieve equivalent antibody function after SARS-CoV-2 infection or vaccination.
Journal: Frontiers in immunology
Published: May 30, 2023
Shared N417-Dependent Epitope on the SARS-CoV-2 Omicron, Beta, and Delta Plus Variants.
Journal: Journal of virology
Published: July 22, 2022
Antibody-dependent cellular cytotoxicity against SARS-CoV-2 Omicron sub-lineages is reduced in convalescent sera regardless of infecting variant.
Journal: Cell reports. Medicine
Published: June 26, 2022
Decline in antibody responses to SARS-CoV-2 post-vaccination poses a risk to health care workers.
Journal: The Journal of infection
Published: June 07, 2022
Last Updated: 09/26/2026